The Purpose of this study is to 1) investigate prevalence of diastolic dysfunction in patients with morbid obesity attending a conservative lifestyle change program, 2) investigate effects on cardiac function, cardiorespiratory Fitness, body composition, quality of life and cardiovascular risk through the program, 3) investigate feasibility of introducing two different activity monitors throughout the program, and 4) comparing compliance to activity sensor market leader FitBit Application versus Mio Pai Application
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
57
Prescription: Target 100 PAI Points per week
Prescription: Target daily 10.000 steps
LHL-Klinikkene
Røros, Norway
diastolic dysfunction
echocardiac examination at baseline assessed by GE Healthcare Vivid E9, Horten, Norway
Time frame: 18 months
diastolic function
echocardiac examination assessed by GE Healthcare Vivid E9, Horten, Norway
Time frame: 4 months
diastolic function
echocardiac examination assessed by GE Healthcare Vivid E9, Horten, Norway
Time frame: 12 months
Cardiorespiratory fitness
Peak oxygen uptake assessed by Jaeger oxycon pro; Erich Jaeger GmbH, Hoechberg, Germany
Time frame: 4 months
Cardiorespiratory fitness
Peak oxygen uptake assessed by Jaeger oxycon pro; Erich Jaeger GmbH, Hoechberg, Germany
Time frame: 12 months
Cardiorespiratory fitness
Peak oxygen uptake assessed by Jaeger oxycon pro; Erich Jaeger GmbH, Hoechberg, Germany
Time frame: 18 months
Body composition
Body composition assessed by bioelectrical impedance (instrument InBody 770, produced by BIOSPACE, Seoul, Korea)
Time frame: 4 months
Body composition
Body composition assessed by bioelectrical impedance (instrument InBody 770, produced by BIOSPACE, Seoul, Korea)
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Body composition
Body composition assessed by bioelectrical impedance (instrument InBody 770, produced by BIOSPACE, Seoul, Korea)
Time frame: 18 months
Body Mass Index
Weight derived by squared height
Time frame: 4 months
Body Mass Index
Weight derived by squared height
Time frame: 12 months
Body Mass Index
Weight derived by squared height
Time frame: 18 months
Waist line
tape measure in centimeters
Time frame: 4 months
Waist line
tape measure in centimeters
Time frame: 12 months
Waist line
tape measure in centimeters
Time frame: 18 months
Physical Activity Questionnaire
HUNT 1 physical activity questionnaire
Time frame: 4 months
Physical Activity Questionnaire
HUNT 1 physical activity questionnaire
Time frame: 12 months
Physical Activity Questionnaire
HUNT 1 physical activity questionnaire
Time frame: 18 months
Quality of life
Impact of Weight on Quality of Life Short Form (IWQOL-Lite); Kolotkin
Time frame: 4 months
Quality of life
Impact of Weight on Quality of Life Short Form (IWQOL-Lite); Kolotkin
Time frame: 12 months
Quality of life
Impact of Weight on Quality of Life Short Form (IWQOL-Lite); Kolotkin
Time frame: 18 months
Symptoms of anxiety and depression
Hospital Anxiety and Depression Scale; Zigmond \& Snaith
Time frame: 4 months
Symptoms of anxiety and depression
Hospital Anxiety and Depression Scale; Zigmond \& Snaith
Time frame: 12 months
Symptoms of anxiety and depression
Hospital Anxiety and Depression Scale; Zigmond \& Snaith
Time frame: 18 months
Glucose concentration in blood
Time frame: 4 months
Glucose concentration in blood
Time frame: 12 months
Glucose concentration in blood
Time frame: 18 months
Glycosylated haemoglobin (HbA1c) concentration in blood
Time frame: 4 months
Glycosylated haemoglobin (HbA1c) concentration in blood
Time frame: 12 months
Glycosylated haemoglobin (HbA1c) concentration in blood
Time frame: 18 months
LDL concentration in blood
Low Density Cholesterol
Time frame: 4 months
LDL concentration in blood
Low Density Cholesterol
Time frame: 12 months
LDL concentration in blood
Low Density Cholesterol
Time frame: 18 months
HDL concentration in blood
High Density Cholesterol
Time frame: 4 months
HDL concentration in blood
High Density Cholesterol
Time frame: 12 months
HDL concentration in blood
High Density Cholesterol
Time frame: 18 months
Concentration of total cholesterol in blood
Time frame: 4 months
Concentration of total cholesterol in blood
Time frame: 12 months
Concentration of total cholesterol in blood
Time frame: 18 months
Concentration of triglycerides in blood serum
Time frame: 4 months
Concentration of triglycerides in blood serum
Time frame: 12 months
Concentration of triglycerides in blood serum
Time frame: 18 months
Concentration of HS-CRP in blood serum
High Sensitive C-reactive protein
Time frame: 4 months
Concentration of HS-CRP in blood serum
High Sensitive C-reactive protein
Time frame: 12 months
Concentration of HS-CRP in blood serum
High Sensitive C-reactive protein
Time frame: 18 months
C-peptide concentration in blood
Time frame: 4 months
C-peptide concentration in blood
Time frame: 12 months
C-peptide concentration in blood
Time frame: 18 months
Leukocyte concentration in blood
Time frame: 4 months
Leukocyte concentration in blood
Time frame: 12 months
Leukocyte concentration in blood
Time frame: 18 months
Potassium (K) concentration in blood
Time frame: 4 months
Potassium (K) concentration in blood
Time frame: 12 months
Potassium (K) concentration in blood
Time frame: 18 months
Sodium (Na) concentration in blood
Time frame: 4 months
Sodium (Na) concentration in blood
Time frame: 12 months
Sodium (Na) concentration in blood
Time frame: 18 months
Creatinine concentration in blood
Time frame: 4 months
Creatinine concentration in blood
Time frame: 12 months
Creatinine concentration in blood
Time frame: 18 months
Apo-A concentration in blood serum
Apolipoprotein A
Time frame: 4 months
Apo-A concentration in blood serum
Apolipoprotein A
Time frame: 12 months
Apo-A concentration in blood serum
Apolipoprotein A
Time frame: 18 months
Apo-B concentration in blood serum
Apolipoprotein B
Time frame: 4 months
Apo-B concentration in blood serum
Apolipoprotein B
Time frame: 12 months
Apo-B concentration in blood serum
Apolipoprotein B
Time frame: 18 months
NT-ProBNP concentration in plasma
N-Terminal Brain Natriuretic Peptide
Time frame: 4 months
NT-ProBNP concentration in plasma
N-Terminal Brain Natriuretic Peptide
Time frame: 12 months
NT-ProBNP concentration in plasma
N-Terminal Brain Natriuretic Peptide
Time frame: 18 months
Lp(a) concentration in blood serum
Lipoprotein(a)
Time frame: 4 months
Lp(a) concentration in blood serum
Lipoprotein(a)
Time frame: 12 months
Lp(a) concentration in blood serum
Lipoprotein(a)
Time frame: 18 months